510(k) Report

510(k) · Cleared

Cleared

0.9.% Sodium Chloride Inhalation Solution, Usp

K974056510(k) TraditionalCleared Jan 21, 199886-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Holopack International, LP · CAF Nebulizer (Direct Patient Interface)

Cleared on Jan 21, 1998 as substantially equivalent to K884359 (Automatic Liquid Packaging, Inc., 1988) and 1 other predicate after an 86-day review. Its family tree reaches back 1 generation to 1987.

Decided
Jan 21, 1998
Review
86 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K870332 (1987). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1988: 1 other ancestorK870332 · Prefilled Respiratory Therapy Vials · Automatic Liquid Packaging, Inc. · 19871985199019952000
Other ancestors, by generation 1 generation back: 1 other ancestor K870332 · Prefilled Respiratory Therapy Vials · Automatic Liquid Packaging, Inc. · 19870
  1. Root · 1 generation backK870332 Prefilled Respiratory Therapy VialsAutomatic Liquid Packaging, Inc. · 1987
  2. This deviceK974056 0.9.% Sodium Chloride Inhalation Solution, UspHolopack International, LP · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K870332Prefilled Respiratory Therapy VialsAutomatic Liquid Packaging, Inc.1987—
0 (this device)K9740560.9.% Sodium Chloride Inhalation Solution, UspHolopack International, LP1998—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
FIG. 1 — Lineage of K974056, 1987–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K884359Unit Dose 3% Sodium Chloride Solution for Inhala.
Summary page 2
…ate Devices to which Equivalence is Claimed There are several comparable devices manufactured prior to 1976 and/or those to which Substantial Equivalence is claimed. K884359 Unit Dose 0.45%; 0.9% ; 3% Sodium Chloride Solution for Inhalation in 3, 5 and 15mL containers K870332 Automatic Liquid Packagi…
Automatic Liquid Packaging, Inc.1988—
*K870332Prefilled Respiratory Therapy Vials
Summary page 2
…1976 and/or those to which Substantial Equivalence is claimed. K884359 Unit Dose 0.45%; 0.9% ; 3% Sodium Chloride Solution for Inhalation in 3, 5 and 15mL containers K870332 Automatic Liquid Packaging, Inc. 2200 W. Lake Shore Drive - Woodstock, IL 60096 'K8703320 Travenol Laboratories ( pre-1976) W…
Automatic Liquid Packaging, Inc.1987—
*—Travenol Laboratories (pre-1976)
Named without a submission number
—
*—Wyeth Laboratories, Inc. (pre-1976)
Named without a submission number
—
*—Respiratory Therapy Vials Sodium Chloride Inhalation Solution
Named without a submission number
—

Also cleared against K884359: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K884359.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The intended use of these sterile single use devices is as accessories to medicinal non-ventilatory nebulizers in respiratory therapy or for tracheal irrigation or lavage.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K974056: 0.9.% Sodium Chloride Inhalation Solution, Usp.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K974056

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026